Accuray Receives Shonin Approval for ClearRT™ Helical kVCT Imaging, CE Mark Expected by End of June; Expands Commercial Launch
Retrieved on:
Thursday, April 22, 2021
The team has more than 18 years\' experience treating patients with the TomoTherapy System and recently upgraded to the Radixact System, the next-generation TomoTherapy platform.
Key Points:
- The team has more than 18 years\' experience treating patients with the TomoTherapy System and recently upgraded to the Radixact System, the next-generation TomoTherapy platform.
- The ClearRT daily targeting images exceeded our expectations, and provided noticeably superior image quality compared to more traditional cone-beam CT available on conventional linear accelerators.
- The imaging technology will now be available in Japan and the U.S. ClearRT imaging is expected to be accessible to EU customers following receipt of the CE Mark.
- "\n*ClearRTHelical kVCT Imaging for the RadixactTreatment Delivery System is not available for sale in all markets.